13F Holdings
中文EN

ACNT ASCENT INDUSTRIES CO.

Chemicals & Allied Products · Nasdaq · SEC CIK 95953 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY22.4%
TTM net income YoY-207.7%
TTM EPS YoY-211.1%
Revenue 3-yr CAGR-23.9%
Net income 3-yr CAGR—

Margins

Gross margin20.8%
Operating margin-2.7%
Net margin-1.0%
FCF margin-8.7%
EBITDA margin-1.3%

Returns

ROE-1.1%
ROA-0.8%
ROIC (approx.)-4.8%
Asset turnover0.80x

Leverage & solvency

Liabilities / assets24.6%
Debt / equity0.00x
Current ratio4.50x
Interest coverage—

Cash quality & payout

Operating cash flow / net income5.48x
Accruals ratio3.7%
Payout ratio—
Capex / revenue3.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$74.94M$80.76M$193.18M$261.99M$334.71M
Cost of revenue$57.73M$70.07M$191.65M$218.71M$273.95M
Gross profit$17.21M$10.69M$1.53M$43.29M$60.77M
R&D expense$71,000$0———
SG&A expense$22.96M$19.86M$26.71M$27.64M$30.14M
Operating income-$7.03M-$10.80M-$37.43M$14.54M$27.35M
Interest expense—$418,000$4.24M$2.74M$1.49M
Pretax income-$5.56M-$10.77M-$41.08M$12.01M$25.50M
Income tax$22,000$1.81M-$6.92M-$5.57M$5.25M
Net income$867,000-$13.60M-$26.63M$22.07M$20.25M
EBITDA-$5.89M-$9.76M-$31.27M$20.96M$37.69M
EPS (basic)0.09-1.35-2.632.162.17
EPS (diluted)0.09-1.35-2.632.122.14
Dividends declared per share0.000.000.000.000.00
Weighted avg. shares (diluted)9.64M10.11M10.14M10.41M9.46M
Balance sheet
Cash & equivalents$57.61M$16.11M$1.84M$1.44M$2.02M
Receivables$10.04M$12.23M$15.10M$33.20M$33.42M
Inventory$8.74M$5.73M$52.31M$67.67M$103.25M
Current assets$83.02M$83.07M$89.41M$170.38M$159.98M
PP&E, net$15.76M$17.59M$29.75M$35.53M$43.72M
Goodwill$0$0$0$11.39M$12.64M
Intangibles$2.83M$3.44M$8.50M$10.00M$14.38M
Total assets$111.94M$147.25M$163.29M$269.04M$266.00M
Current liabilities$12.36M$22.35M$24.79M$33.48M$50.49M
Short-term debt——$0$2.46M$2.46M
Long-term debt—$0$0$69.08M$67.93M
Total debt—$0$0$71.55M$70.39M
Total liabilities$24.95M$53.70M$55.88M$134.78M$154.41M
Shareholders' equity$86.99M$93.55M$107.41M$134.26M$111.59M
Net debt—-$16.11M-$1.84M$70.11M$68.38M
Shares outstanding9.40M10.07M10.07M10.09M10.16M
Cash flow statement
Operating cash flow-$519,000$14.68M$23.08M$5.58M$19.05M
Capital expenditure$1.54M$1.12M$2.88M$3.39M$1.50M
Free cash flow-$2.06M$13.56M$20.19M$2.18M$17.56M
Investing cash flow$50.98M$905,000$50.50M-$4.97M-$32.66M
Financing cash flow-$8.96M-$1.33M-$73.17M-$1.18M$15.39M
Depreciation & amortization$1.13M$1.04M$6.16M$6.42M$10.34M
Stock-based compensation$1.30M$760,000$1.02M$1.35M$799,000
Share buybacks$9.14M$1.04M$1.29M$1.34M$0

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.